The relationship between lipid peroxidation and LDL desialylation in experimental atherosclerosis

Toxicology Mechanisms and Methods

Volumn 17, Issue 5, 2007, Pages 265-273

  Öztürk, Zeynep ^a,c   Sönmez, Hüseyin ^a   Görgün, F Murat ^a   Ekmekçi, Hakan ^a   Bilgen, Dilek ^a   Özen, Naile ^a   Sözer, Volkan ^b   Altuǧ, Tuncay ^a   Kökoǧlu, Emine ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b YILDIZ TECHNICAL UNIVERSITY   (Turkey)

^c Gökyüzü 4 Mahalle ^*  (Turkey)

Author keywords

Atherosclerosis; LDL Desialylation; Sialic Acid; Sialidase; TBARS

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIALIC ACID; SIALIDASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT; SIALYLATION; TRIACYLGLYCEROL BLOOD LEVEL;

ORYCTOLAGUS CUNICULUS;

EID: 34250755925     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510600992608     Document Type: Article

References (42)

1. Allon, R., Bayer, E. A., and Wilchek, M. 1991. A coupled enzyme assay for measurement of sialidase activity. J. Biochem. Biophys. Methods 22:23-33.
2. Aviram, M. 1991. The contribution of macrophage receptor for oxidized LDL to its cellular uptake. Biochem. Biophys. Res. Commun. 179:359-365.
3. Aviram, M. 1993. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 98:1-9.
4. Barbosa, D. S., Maranhoa, R. C., Arauja, F. B., Chang, Y. J., Hirata, M. H., and Abdalla, D. S. 1995. Sialic acid and oxidazibility of low density lipoprotein subfractions of hyperlipidemic patients. Clin. Biochem. 28:435-441.
5. Brousseau, T., Clavey, V., Bard, J. M., and Fruchart, J. C. 1993. Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins and lipoprotein particles. Clin. Chem. 39:960-964.
6. Buege, J. A., and Aust, S. D. 1978. Microsomal lipid peroxidation. Methods Enzymol. 52:302-310.
7. Dousset, N., Dousset, J. C., Taus, M., Ferretti, G., Curatola, G., Solera, M. L., and Valdique, P. 1994. Effect of desialylation on low density lipoproteins: comparative study before and after oxidative stress. Biochem. Mol. Biol. Int. 32:555-563.
8. Dousset, N., Ferretti, G., Taus, M., Solera, M., Dousset, J. C., and Valdique, P. 1998. Physico-chemical modifications in desialylated low density lipoproteins. Nutr. Metab. Cardiovasc. Dis. 8:366-370.
9. Hessler, J. R., Robertson, A. L., and Chilsom, G. M. 1979. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 32:213-229.
10. Jurgens, G., Hoff, H. F., and Chisolm, G. M. 1987. Modification of human serum low density lipoprotein by oxidation-characterization and pathophysiological implications. Chem. Phys. Lipids 45:315-336.
11. Keidar, S., Brook, J. G., Rosenbalt, M., Fhrman Danker, G., and Aviram, M. 1992. Involvement of macrophage LDL receptor binding domains in the uptake of oxidized LDL. Arterioscl. Thromb. 4:484-493.
12. Kimura, N., and Keys, A. 1970. Coronary heart disease in seven countries. X. Rural southern Japan. Circulation 41:101-112.
13. Knott, T. J., Pease, P. J., Powell, L. M., Wallis, S. C., Rall, S. C. Jr., Blackhart, B., Taylor, W. L. L., Marceal, Y., and Milne, R. 1986. Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature 323:734-738.
14. Kokoglu, E., Suer, S., Sonmez, H., and Ucisik, N. 1996. The relationship between the electrophoretic mobility of lipoproteins and coronary heart disease. Res. Commun. Mol. Pathol. Pharmacol. 91:109-116.
15. La Belle, M., and Krauss, R. M. 1990. Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclasses patterns. J. Lipid. Res. 31:1577-1588.
16. Lowry, O. H., Rosenbrough, N. J., Furn, A. C., and Randall, R. J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265.
17. Martin, M. J., Hully, S. B., Browner, W. S., Kuller, L. H., and Wentworth, D. 1986. Serum cholesterol, blood pressure and mortality: implications from a cohort of 361 662 men. Lancet 2:933-936.
18. Millar, J. S., Anber, V., Shepherd, J., and Packard, C. J. 1999. Sialic acid-containing components of lipoproteins influence lipoprotein-proteoglycan interactions. Atherosclerosis 145:253-260.
19. Myara, I., Haberland, M. E., Demuth, K., Chappey, B., and Moatti, N. 1995. Susceptibility to copper oxidation of neuraminidase treated LDL. Clin. Chim. Acta. 240:221-223.
20. Orekhov, A. N., Tertov, V. V., Mukhin, D. N., and Mikhailenko, I. A. 1989. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem. Biophys. Res. Commun. 162:206-211.
21. Orekhov, A. N., Tertov. V. V., and Mukhin, D. N. 1991 Desialylated low density lipoprotein naturally occurring modified lipoprotein with atherogenic potency. Atherosclerosis 86:153-161.
22. Orekhov, A. N., Tertov, V. V., Pokrovsky, S. N., Adamova, I. Yu., Martsenyuk, O. N., Lyakishev, A. A., and Smirnov, V. N. 1988. Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination. Circ. Res. 62:421-429.
23. Orekhov, A. N., Tertov, V. V., Sobenin, I. A., Smirnov, V. N., Via, D. P., Guevara, J. Jr., Gotto, A. M. Jr., and Morrisett, J. D. 1992. Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J. Lipid Res. 33:805-817.
24. Sattler, W., Kostner, G. M., Waeg, G., and Esterbauer, H. 1991. Oxidation of lipoprotein Lp(a). A comparison with low density lipoproteins. Biochim. Biophys. Acta 1081:65-74.
25. Schwartz, C. J., Valente, A. J., and Sprague, E. A. 1993. A modern view of atherogenesis. Am. J. Cardiol. 71:9B-14B.
26. Sobenin, I. A., Tertov, V. V., Konchinsky, T., Bünting, C. E., Slavina, E. S., Dedov, I. I., and Orekhov, A. N. 1993. Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells. Atherosclerosis 100:41-54.
27. Sonmez, H., Suer, S., Ulutin, T., Kokoǧlu, E., and Üçişik, N. 1998. The relationship of various factors in the pathogenesis of atherosclerosis. Clin. Appl. Thrombosis/Hemostasis 4:105-110.
28. Sparow, C. P., Parhasarathy, S., and Steinberg, D. 1989. Macrophage receptor that recognizes oxidized LDL not acetylated LDL. J. Biol. Chem. 264:2599-2604.
29. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., and Witztum, J. L. 1989. Beyond cholesterol: modification of low density lipoprotein that increase its atherogenecity. New Engl. J. Med. 320:915-924.
30. Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Wiztum, J. L., and Steinberg, D. 1984. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81:3883-3887.
31. Swaminathan, N., and Aladjen, F. 1976. The monosaccharide composition and sequence of the carbohydrate moiety of human serum low density lipoproteins. Biochemistry 15:1516-1522.
32. Tanaka, K., Tokumaru, S., and Kojo, S. 1997. Possible involvement of radical reactions in desialylation of LDL. FEBS Lett. 413:202-204.
33. Taniguchi, T., Ishikawa, Y., Tsunemitsu, M., and Fukuzaki, I. I. 1989. The structures of the asparagine-linked sugar chains of human apolipoprotein B-100. Arch. Biochem. Biophys. 273:197-205.
34. Tertov, V. V., Kaplun, V. V., Sobenin, I. A., Boytsova, E. Y., Bovin, N. V., and Orekhov, A. N. 2001. Human plasma trans-sialidase causes atherogenicmodification of low density lipoprotein. Atherosclerosis 159(1):103-115.
35. Tertov, V. V., Kaplun, V. V., Sobenin, I. A., and Orekhov, A. N. 1998. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification. Atherosclerosis 138:183-195.
36. Tertov, V. V., Orekhov, A. N., Martsenyuk, O. N., Perova, N. V., and Smirnov, V. N. 1989. Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells. Exp. Mol. Pathol. 50:337-347.
37. Tertov, V. V., Orekhov, A. N., Sobenin, I. A., Morrisett, J. D., Gotto, A. M. Jr., Guevara, J. G. Jr. 1993. Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with andwithout coronary artery disease. J. Lipid Res. 34:365-375.
38. Tertov, V. V., Sobenin, I. A., Gabbasov, Z. A., Popov, E. G., Jaakkola, O., Solakivi, T., Nikkari, T., Smirnov, V. N., and Orekhov, A. N. 1992. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. . Lab Invest 67:665-675.
39. Tertov, V. V., Sobenin, I. A., Orekhov, A. N., Jaakkola, O., Solakivi, T., and Nikkari, T. 1996. Characteristics of low density lipoprotein isolated from circulating immune complexes. Atherosclerosis 122:191-199.
40. Wang, M. 2001. Atherosclerosis: the past, the present and the future. Atherosclerosis 3:1-25.
41. Warren, L. 1959. The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234:1971-1975.
42. Witztum, J. L., and Steinberg, D. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1875-1892.